ELIXIRON IMMUNOTHERAPEUTICS INC.
Update:2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Develop innovative therapies for cancer and immunological diseases.
Founded Year
2017
Unified Business No.
52625245
Status
Active
Number of Employees
0
Total Paid-in
Capital
621,180,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Elixiron Immunotherapeutics employs advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics from phage display and single human B cell cloning platforms, to develop innovative therapies for cancer and immunological diseases.